Endpoint definition
↥| Name | OSTPOPATFRACTURE |
|---|---|
| Long name | Drug-induced osteoporosis with pathological fracture |
| First defined in version | DF2 |
| Latin name | Osteoporosis e medicamento cum fractura pathologica |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 156 | 120 | 36 |
| Unadjusted prevalence (%) | 0.07 | 0.10 | 0.04 |
| Mean age at first event (years) | 63.91 | 63.58 | 65.02 |
| Case fatality at 5-years (%) | 7.69 | 6.67 | 11.11 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 3.0 | 1.0 |
| Recurrence at 6 months (%) | 52.56 | 57.50 | 36.11 |
Survival analyses between endpoints
↥Plot
before Drug-induced osteoporosis with pathological fracture
after Drug-induced osteoporosis with pathological fracture
Loading survival analyses plot…
Table
Loading survival analyses table…